Ledger.Open graph →
SEC Form D · Amendment · filed November 17, 2022

Switch Therapeutics Inc

Offering
$36.0M
Sold
$23.3M
Exemption
Rule 506(b)
Industry
Other
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Alicia Irurzun-Lafitte · South San Francisco, CADirectorDylan Morris · South San Francisco, CADirectorSi-Ping Han · South San Francisco, CAExecKevin Zhang · South San Francisco, CADirectorDeepshikha Datta · South San Francisco, CAExec · DirectorGarrett Johnson · Miami, FLDirectorJake Stenziano · KNOXVILLE, TNExecChristopher T. Mcguire · New York, NYExec · DirectorBradley Whiting · BELFAIR, WADirectorAaron Ginn · Miami, FLDirectorMatthew P. Jacobson · SOUTH SAN FRANCISCO, CADirectorThilo H. Schroeder · SOUTH SAN FRANCISCO, CADirectorWalter H. Moos · SOUTH SAN FRANCISCO, CADirectorJames H. Evangelista · SOUTH SAN FRANCISCO, CAExecDavid J. Earp · SOUTH SAN FRANCISCO, CAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗